Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

OM-174 shows in vivo antitumor activity

March 15, 1996

Glaxo Wellcome reports antitumor drugs

March 15, 1996

Marimastat enters phase II in U.S.

March 15, 1996

Techniclone establishes distribution agreement for Oncolym

March 15, 1996

New antimitotic drugs from Pharmacia & Upjohn

March 15, 1996

More approvals for Taxotere

March 15, 1996

Paclitaxel derivatives from Bristol-Myers Squibb

March 15, 1996

FDA gives green light to Immunex's etoposide

March 15, 1996

European clinical trial results with irinotecan reported

March 15, 1996

PK1 to enter phase II

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...